Transitioning from Intravenous to Oral Furosemide

Principles of Conversion

The American Association for the Study of Liver Diseases recommends that furosemide has good oral bioavailability in patients with cirrhosis, favoring the use of the oral route when the patient is stable 1, 2
The European Society of Cardiology suggests confirming that the patient is hemodynamically stable before transitioning from intravenous to oral furosemide 3
The American Association for the Study of Liver Diseases notes that verifying an adequate response to diuresis with the current dose is necessary before transitioning from intravenous to oral furosemide 2

The European Heart Journal recommends calculating the equivalent oral dose, considering the reduced oral bioavailability (60-64%) compared to the intravenous route 3
The American Association for the Study of Liver Diseases suggests administering the first oral dose 12 hours after the last intravenous dose and maintaining the same administration interval (12/12 hours) to preserve the therapeutic effect 2, 4

The American Association for the Study of Liver Diseases recommends evaluating the diuretic response within the first 24-48 hours after the transition 2
The European Society of Cardiology suggests monitoring weight, fluid balance, and signs of congestion after the transition 3
The American Association for the Study of Liver Diseases notes that verifying serum electrolytes, especially potassium and sodium, is necessary after the transition 2, 4

The European Society of Cardiology recommends that patients with heart failure or cirrhosis may have variable oral absorption, requiring dose adjustments based on clinical response 3, 2
The American Association for the Study of Liver Diseases suggests that if the diuretic response is inadequate after the transition, the oral dose can be increased in increments of 40 mg/day 2, 4
The American Association for the Study of Liver Diseases notes that the usual maximum oral dose of furosemide is 160 mg/day in cases of ascites due to cirrhosis 2, 4